Positive pre-clinical proof of concept in MS fatigue model

Chronos announces positive pre-clinical results for the lead compound in its DAT inhibitor programme in an in vivo model of fatigue in multiple sclerosis (MS). Read the press release.

Contact Us

Want to get in touch? Send us an email.

Not readable? Change text. captcha txt